Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Myeloid Leukemia · Myelodysplastic Syndromes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Washington University, St Louis, Missouri, United States
Contact: Study coordinator (Ayan Gasanli, MBA) · agasanli@wustl.edu · 314-747-2449
Contact: Study coordinator (Ryan Monahan, MBA) · rmonahan@wustl.edu · 314-454-8377
Contact: Principal Investigator (John DiPersio, MD, PhD)
UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Linda Elias, RN) · eliaslj@upmc.edu · 412-623-6037
Contact: Study coordinator (Amy Rodger, RN) · rodgax@upmc.edu · 412-623-4036
Contact: Principal Investigator (Sawa Ito, MD, PhD)
Fred Hutchinson Cancer Center, Seattle, Washington, United States
Contact: Study coordinator (Elizabeth Frecker, B.S., SMB-A) · efrecker@fredhutch.org · 206-667-4129
Contact: Study coordinator (Alisa Bradford) · ajbradfo@fredhutch.org · 206-667-2834
Contact: Principal Investigator (Elizabeth Krakow, MD, CM, MS)

Study leads

Sawa M Ito, MD, PhD
Principal Investigator
UPMC Hillman Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia · Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm · Acute Myeloid Leukemia Post Cytotoxic Therapy

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Phoenix, United States

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

Acute Myeloid Leukemia · Essential Thrombocythemia · Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE2

Seattle, United States

First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients

Acute Myeloid Leukemia, Adult · Myelodysplastic Syndromes

Abroad (travel likely)RecruitingPHASE1, PHASE2

Marseille, France · Paris, France

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

Acute Myeloid Leukemia in Remission · Myelodysplastic Syndromes · Chronic Myeloid Leukemia in Remission

Abroad (travel likely)RecruitingPHASE2

Antwerp, Belgium · Bruges, Belgium